CIK 0000874716 · Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010393723
- Phone
- 2075560300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | Britt Irene Chang Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +525 | 525 | ||
| 2026-05-12 | Britt Irene Chang Director | Grant or award · Deferred Stock Unit | +234 | 753 | ||
| 2026-05-07 | Vandebroek Sophie V. Director | Option exercise | +257 | 905 | ||
| 2026-05-07 | Vandebroek Sophie V. Director | Option exercise · Restricted Stock Unit | −257 | 0 | ||
| 2026-05-07 | SZOSTAK M ANNE Director | Option exercise | +257 | 519 | ||
| 2026-05-07 | SZOSTAK M ANNE Director | Option exercise · Restricted Stock Unit | −257 | 0 | ||
| 2026-05-07 | Peacock Karen Director | Option exercise | +101 | 102 | ||
| 2026-05-07 | Peacock Karen Director | Option exercise · Restricted Stock Unit | −101 | 0 | ||
| 2026-05-07 | Kingsley Lawrence D Director | Option exercise | +257 | 9,486 | ||
| 2026-05-07 | Kingsley Lawrence D Director | Option exercise | +82 | 9,568 | ||
| 2026-05-07 | Kingsley Lawrence D Director | Option exercise · Restricted Stock Unit | −257 | 0 | ||
| 2026-05-07 | Kingsley Lawrence D Director | Option exercise · Restricted Stock Unit | −82 | 0 | ||
| 2026-05-07 | JUNIUS DANIEL M Director | Option exercise | +257 | 3,561 | ||
| 2026-05-07 | JUNIUS DANIEL M Director | Option exercise · Restricted Stock Unit | −257 | 0 | ||
| 2026-05-07 | HOOLEY JOSEPH L Director | Option exercise | +158 | 276 | ||
| 2026-05-07 | HOOLEY JOSEPH L Director | Option exercise · Restricted Stock Unit | −158 | 0 | ||
| 2026-04-30 | HOOLEY JOSEPH L Director | Grant or award | +43 | $560.80 | $24K | 118 |
| 2026-03-03 | Underberg Sharon E. EVP, GC & Corporate Secretary | Option exercise | +197 | $505.53 | $100K | 7,137.65 |
| 2026-03-03 | Underberg Sharon E. EVP, GC & Corporate Secretary | Option exercise · Incentive Stock Option (right-to-buy) | −197 | 0 | ||
| 2026-03-03 | Hunt Nimrata Executive Vice President | Sale | −1,758 | $634.57 | $1.1M | 18,140.94 |
Page 4 of 28 · 552 trades